Comparison of rabbit and mouse models for persistence analysis of plasmid-based vaccines

Human Vaccines

Volumn 2, Issue 3, 2006, Pages 113-118

  Leamy, Vicky L ^a   Martin, Terrie ^a   Mahajan, Rohit ^a   Vilalta, Adrian ^a   Rusalov, Denis ^a   Hartikka, Jukka ^a   Bozoukova, Vesselina ^a   Hall, Keith D ^a   Morrow, Jane ^a   Rolland, Alain P ^a   Kaslow, David C ^a   Lalor, Peggy A ^a  

^a VICAL INC   (United States)

Author keywords

Anthrax vaccine; Biodistribution; Cationic lipid formulation; Injection volume; Pharmacokinetics; Plasmid based vaccines; Real time PCR

Indexed keywords

CATION; DNA VACCINE; GENOMIC DNA; LIPID; PLASMID BASE VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG CLEARANCE; DRUG DISTRIBUTION; MOUSE; NONHUMAN; PLASMID; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; THEORETICAL MODEL;

EID: 33748043678     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.2836     Document Type: Article

References (13)

1. Gonin P, Gaillard C. Gene transfer vector biodistribution: Pivotal safety studies in clinical gene therapy development. Gene Ther 2002; 11:S98-108.
2. Quezada A, Larson J, French M, Ponce R, Perrard J, Durland R, Coleman M. Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models. J Pharm Pharmacol 2004; 56:177-85.
3. Kang KK, Choi SM, Choi JH, Lee DS, Kim CY, Ahn BO, Kim BM, Kim WB. Safety evaluation of GX-12, a new HIV therapeutic vaccine: Investigation of integration into the host genome and expression in the reproductive organs. Intervirology 2003; 46:270-6.
4. Hanke T, McMichael AJ, Samuel RV, Powell LA, McLoughlin L, Crome SJ, Edlin A. Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya. Vaccine 2002; 21:108-114.
5. Ledwith BJ, Manam S, Troilo PJ, Barnum AB, Pauley CJ, Griffiths IInd TG, Harper LB, Schock HB, Zhang H, Faris JE, Way PA, Beare CM, Bagdon WJ, Nichols WW. Plasmid DNA vaccines: Assay for integration into host genomic DNA. Dev Biol (Basel) 2002; 104:33-43.
6. Manam S, Ledwith BJ, Barnum AB, Troilo PJ, Pauley CJ, Harper LB, Griffiths IInd TG, Niu Z, Denisova L, Follmer TT, Pacchione SJ, Wang Z, Beare CM, Bagdon WJ, Nichols WW. Plasmid DNA vaccines: Tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 2000; 43:273-81.
7. Parker SE, Borellini F, Wenk ML, Hobart P, Hoffman SL, Hedstrom R, Le T, Norman JA. Plasmid DNA malaria vaccine: Tissue distribution and safety studies in mice and rabbits. Hum Gene Ther 1999; 10:741-58.
8. Winegar RA, Monforte JA, Suing KD, O'Loughlin KG, Rudd CJ, Macgregor JT. Determination of tissue distribution of an intramuscular plasmid vaccine using PCR and in situ DNA hybridization. Hum Gene Ther 1996; 7:2185-94.
9. Vilalta A, Mahajan RK, Hartikka J, Rusalov D, Martin T, Bozoukova V, Leamy V, Hall K, Lalor P, Rolland A, Kaslow DC. Poloxamer-formulated plasmid DNA-based human CMV vaccine: Evaluation of pDNA biodistribution/persistence and integration. Hum Gene Ther 2005; 16:1143-50.
10. Vilalta A, Mahajan RK, Hartikka J, Leamy V, Martin T, Rusalov D, Bozoukova V, Lalor P, Hall K, Kaslow DC, Rolland A. Cationic lipid-formulated plasmid DNA-based bacillus anthracis vaccine: Evaluation of pDNA persistence and integration potential. Hum Gene Ther 2005; 16:1151-6.
11. Dupuis M, Denis-Mize K, Woo C, Goldbeck C, Selby MJ, Chen M, Otten GR, Ulmer JB, Donnelly JJ, Ott G, McDonald DM. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 2000; 165:2850-8.
12. Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. Proc Natl Acad Sci USA 2004; 101:13601-6.
13. Martin T, Parker SE, Hedstrom R, Le T, Hoffman SL, Norman J, Hobart P, Lew D. Plasmid DNA malaria vaccine: The potential for genomic integration after intramuscular injection. Hum Gene Ther 1999; 10:759-68.